UP!

News

Celator Pharmaceuticals, Inc. (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-06-01 Downgrade Janney Montgomery Scott Buy to Neutral
2016-06-01 Downgrade Stifel Nicolaus Buy to Hold
2016-05-31 Downgrade Needham & Company LLC Buy to Hold
2016-05-31 Downgrade Roth Capital Buy to Neutral $30.25 to $26.00
2016-05-19 Reiterated Rating Roth Capital Buy $22.00 to $26.00
2016-04-22 Initiated Coverage Stifel Nicolaus Buy $23.00
2016-04-12 Reiterated Rating Roth Capital Buy $22.00
2016-04-12 Initiated Coverage Needham & Company LLC Buy $24.00
2016-03-22 Reiterated Rating Roth Capital Buy $22.00
2016-03-15 Boost Price Target Roth Capital Buy $18.00 to $22.00
2016-03-15 Boost Price Target HC Wainwright Buy $20.00
2016-03-15 Initiated Coverage Janney Montgomery Scott Buy $13.00
2015-10-30 Reiterated Rating FBR & Co. Outperform
2015-10-30 Reiterated Rating FBR & Co Outperform
2015-09-25 Reiterated Rating Roth Capital Buy
2015-08-12 Reiterated Rating MLV & Co. Buy $6.00
2015-07-27 Boost Price Target Roth Capital Buy $15.00 to $18.00
2015-07-17 Reiterated Rating Roth Capital Buy $15.00
2015-06-26 Initiated Coverage MLV & Co. Buy
2015-06-26 Reiterated Rating Roth Capital Buy $15.00
2015-06-26 Reiterated Rating HC Wainwright Buy
2015-06-19 Initiated Coverage MLV & Co. Buy $6.00
2015-06-08 Reiterated Rating Roth Capital Buy $15.00
2014-09-05 Initiated Coverage HC Wainwright Buy $7.00
2016-06-01 Downgrade Janney Montgomery Scott Buy to Neutral
2016-06-01 Downgrade Stifel Nicolaus Buy to Hold
2016-05-31 Downgrade Needham & Company LLC Buy to Hold
2016-05-31 Downgrade Roth Capital Buy to Neutral $30.25 to $26.00
2016-05-19 Reiterated Rating Roth Capital Buy $22.00 to $26.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In CPXX 1 funds of 2210 total. Show all

Fund name Ticker shares
RUSSELL FRANK CO/ 0.12M

Major Shareholders

Name Relationship Total Shares Holding stocks
VENTURES WEST CAPITAL LTD 8.23%  (2146372) CPXX /
QUAKER BIO VENTURES LP 2.26%  (590427) CPXX / OCRX / RGDO /

Comments